Interview of Kypros Nicolaides

Conducted 11 July 2018 in Antwerp, Belgium, by the Co-Chairs of the ISPD Reproductive Screening Special Interest Group, Lorraine Dugoff, MD (questions 1-7) and Liona Poon, MD (questions 8-13)

Click/Tap a link below to view on the ISPD Education YouTube Channel.

Question 1:  Are you opposed to using cfDNA test as a first line test to all women?

Question 2:  How have you integrated the cfDNA test with ultrasound scan in the first trimester of pregnancy?

Question 3:  Is there any role for serum screening for woean who have had a cfDNA test?

Question 4:  What is your opinion on using cfDNA tests for twins?

Question 5:  How is the fraction rate important?

Question 6:  What will be the ideal timing for the cfDNA test and the mini anomaly scan?

Question 7:  What do you think are the most important research questions in our field that still need to be addressed?

Question 8:  What are obstacles in offering 1st trimester screening?

Question 9:  What is your opinion on offering 1st trimester pre-eclampsia screening without uterine artery doppler or PLGF?

Question 10:  Should we recommend universal aspirin for all pregnant women?

Question 11:  What is the strategy for term pre-eclampsia?

Question 12:  How do you monitor women at high risk for preterm pre-eclampsia?

Question 13:  What is your opinion on sFlt-1/PIGF as a triage test?